In this publication about the role of Uninflatable during asymmetric dispatch of Sara endosomes, we showed that a GFP-Notch protein (termed N-GFP from a report from the Schweisguth lab, which originally generated this reagent [1]) expressed at endogenous levels through a transgenic bacterial artificial chromosome (BAC) is unable to completely rescue a null Notch allele (Figures S3E and S3F). After publication, we became aware of the fact that the description of the genotype of the fly stock containing the BAC was conveyed with a key imprecision: the second chromosome containing the BAC was not homozygous, unlike indicated in the description of the fly stock (N-GFP versus N-GFP/+). Therefore, we were no longer certain whether the genotype indicated in Figures S3E and S3F was correct. We have now analyzed the fly stock again (N-GFP [1] , as well as a new copy of the line from the Schweisguth lab, N-GFP [2] ) and found that, indeed, we can confirm the statement in our publication: N-GFP from the two stocks was not able to completely rescue the N 55e11 null allele.
Indeed, at 18 C (the culture temperature in Figures S3E and S3F in our original report), 44% (n = 54 flies) of the N 55e11 /Y;N-GFP/+ males and 84% (n = 51) of the N 55e11 /N 55e11 ;N-GFP/N-GFP females show a diagnostic loss of Notch function phenotype (second shipment of the stock, N-GFP [2] ): extra dorsocentral and/or scutellar macrochaetae are present in the notum of the relevant genotypes. Examples of this are now shown in an updated Figure S3E . The penetrance of this phenotype is even higher in the first shipment of the stock (N-GFP [1] , 90% penetrance in males (n = 67) and 100% in females (n = 23)). These two relevant genotypes (where there is no issue of dosage compensation) should have shown a full rescue of the Notch phenotype if N-GFP provides all of the Notch functionality.
In addition, at 25 C, the same stocks show a characteristic Abruptex-type Notch gain-of-function phenotype (i.e., loss of vein material in longitudinal veins L4 and L5; now shown in an updated Figure S3F ): in the second shipment of the stock from the Schweisguth lab (N-GFP [2] ), 61% (n = 41) of the N 55e11 /Y;N-GFP/+ males and 80% of the N 55e11 /N 55e11 ;N-GFP/N-GFP females (n = 25) show the loss of L4 vein material, while 100% of these flies show the phenotype in L5. Loss of L2 vein material can also be observed occasionally. The L4 Abruptex phenotype was milder (12% penetrance in females) in the first shipment of the stock (N-GFP [1] ). The extra-macrochaetae phenotypes show much lower penetrance at 25 C.
We also confirmed that these phenotypes are not due to additional mutations (so-called ''modifiers'') in the fly stock, but instead map to N-GFP. Indeed, we now additionally show that (1) in outcrosses of this stock to w 1118 (which would have diluted such modifiers), both the loss-of-function and Ax-type phenotypes are still observed in the progeny in similar frequencies to the original stocks; (2) by using genetic markers to follow and replace all of the chromosomes that could have carried the potential modifiers in the original stocks (with the exception of the BAC-containing second chromosome), we show that the two phenotypes map to the chromosome carrying the N-GFP-containing BAC; and (3) the fact that only 61% and 80% of the ''rescued'' males and females respectively show the L4 phenotype is due not to the free segregation of a potential second hit but to partial penetrance of the gain-of-function phenotype, since in an outcross, parents from the original stocks that did not show the phenotype again yielded progeny with similar phenotypic frequencies to parents that showed the phenotype.
Therefore, similar phenotypes (although with somehow different penetrance and expressivity) were observed using our first and second shipments of the stock. We sequenced the full N-GFP coding DNA sequence in both stocks, which produced identical results. These results fully confirm our report that N-GFP only partially rescues the Notch loss of function. In addition, these results show that the transgene not only is incapable of providing full functionality (as seen at 18 C) but also displays an Abruptextype behavior (at 25 C), a signature of misregulated Notch signaling activity.
In our report, we also showed by immunoprecipitation of fly extracts using anti-GFP antibodies that GFP is cleaved out of N-GFP ( Figures S3A and S3B) . We confirmed the cleavage of the GFP moiety from N-GFP in the first stock in both the input and the immunoprecipitate (Figures S3B, S3C2, and S3C3) . The cleaved GFP could be observed by immunoprecipitation in the second stock received from the Schweisguth lab, although less robustly ( Figure S3C3 ). However, upon outcrossing, the cleaved GFP moiety can be detected more reliably in this second stock ( Figure S3C3 ). This shows that in the second stock, modifiers must have been passively selected to decrease the ectopic cleavage in N-GFP. The fact that outcrossing the N-GFP stock might increase the cleavage of GFP should therefore be kept in mind when using these stocks in outcrosses to generate flies containing other markers and/or mutations in addition to N-GFP. Figure S3 has been updated in our original publication online to include the additional data cited above, and the Figure S3 legend and the genotype descriptions in the section ''Fly lines and fly handling'' in the Supplemental Experimental Procedures
